Dr. Padma  V. Devarajan
My Social Links

Dr. Padma V. Devarajan

Professor
Institute of Chemical Technology, India


Highest Degree
Ph.D. in Pharmaceutics from Institute of Chemical Technology, India

Share this Profile

Biography

Dr. Padma V. Devarajan is presently working as Professor in Pharmacy at Institute of Chemical Technology, India. She has completed his Ph.D. in Pharmaceutics from same Institute. Her main area of interest focuses on Pharmaceutical Sciences and Technology. Her area of expertise includes Pharmaceutics, Nanomedicine, Cell Culture, Pharmacodynamics Evaluation, Anti HIV, Drug Delivery, Drug Targeting, Pharmacokinetics, Bioanalysis, Brain Delivery, Pharmaceutical Formulations, Scaleup, Biodistribution, Anticancer, Liver Targeting, Bioenhancement, Nanoengineering, In vivo studies, Tuberculosis, and Pulmonary targeting. She has 57 publications in journals and 12 books/book chapters as author/co-author.

Area of Interest:

Pharmacology and Toxicology
100%
Pharmaceutical Sciences
62%
Drug Delivery
90%
Pharmaceutics
75%
Pharmaceutical Formulations
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Swati, A.G., D. Shah, M.D. Patel, S.S. Sathaye and P.V. Devarajan, 2015. Polyethylene sebacate-silymarin nanoparticles with enhanced hepatoprotective activity. J. Nanosci. Nanotechnol., 15: 4090-4093.
    CrossRef  |  Direct Link  |  
  2. Malode, V.N., A. Paradkar and P.V. Devarajan, 2015. Controlled release floating multiparticulates of metoprolol succinate by hot melt extrusion. Int. J. Pharma., 491: 345-351.
    CrossRef  |  Direct Link  |  
  3. Jindal, A.B. and P.V. Devarajan, 2015. Asymmetric Lipid- Polymer Particles (LIPOMER) by modified nanoprecipitation: Role of non-solvent composition. Int. J. Pharma., 489: 246-251.
    CrossRef  |  Direct Link  |  
  4. D`Souza, A.A. and P.V. Devarajan, 2015. Asialoglycoprotein receptor mediated hepatocyte targeting � strategies and applications. J. Controlled Release, 203: 126-139.
    CrossRef  |  Direct Link  |  
  5. Soni, M.P., N. Shelkar, R.V. Gaikwad, G.R. Vanage, A. Samad and P.V. Devarajan, 2014. Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis. J. Pharm. Bioallied Sci., 6: 22-30.
    CrossRef  |  Direct Link  |  
  6. Patil, N. and P.V. Devarajan, 2014. Drug Delivery. Insulin loaded alginic acid nanoparticles for sublingual delivery. Drug Delivery, 10.3109/10717544.2014.916769.
    CrossRef  |  Direct Link  |  
  7. Patel, M.D., P.V. Date, R.V. Gaikwad, A. Samad, V.C. Malshe and P.V. Devarajan, 2014. Comparative evaluation of polymeric nanoparticles of rifampicin comprising Gantrez and poly(ethylene sebacate) on pharmacokinetics, biodistribution and lung uptake following oral administration. J. Biomed. Nanotechnol., 10: 687-694.
    CrossRef  |  Direct Link  |  
  8. Nagarsekar, K.S., C.N. Galdhar, R.V. Gaikwad, A. Samad and P.V. Devarajan, 2014. Amphotericin B LIPOMER for Enhanced Splenic Delivery. Drug Delivery Lett., 4: 208-220.
    Direct Link  |  
  9. Khandekar, S.V., M.G. Kulkarni and P.V. Devarajan, 2014. Polyaspartic acid functionalized gold nanoparticles for tumor targeted Doxorubicin delivery. J. Biomed. Nanotechnol., 10: 143-153.
    CrossRef  |  Direct Link  |  
  10. Joshi, V.M. and P.V. Devarajan, 2014. Receptor-mediated hepatocyte-targeted delivery of primaquine phosphate nanocarboplex using a carbohydrate ligand. Drug Delivery Trans. Res., 4: 353-364.
    CrossRef  |  Direct Link  |  
  11. Devarajan, P.V., S.M. Dawre and R. Dutta, 2014. Infectious Diseases: Need for Targeted Drug Delivery In: Targeted Drug Delivery-Concepts and Design Devarajan, P.V. and S. Jain, Springer, India, pp 113-148.
    CrossRef  |  Direct Link  |  
  12. D`Souza, A.A., V.M. Joshi and P.V. Devarajan, 2014. Hepatic Targeting: Physiological Basis and Design Strategy. In: Targeted Drug Delivery-Concepts and Design. Devarajan, P.V. and S. Jain, Springer, India, pp 197-238.
    CrossRef  |  Direct Link  |  
  13. Soni, M.P., M.V. Mahajan, R.V. Dhumal, S. Bhagat and D. Tiwari et al., 2013. Genotoxicity evaluation of asymmetric lipid polymer hybrid nanoparticles of doxycycline hydrochloride following intravenous administration. J. Drug Deliv. Transl. Res., 3: 421-427.
    CrossRef  |  Direct Link  |  
  14. Pranatharthiharan, S., M. Patel, A. D`Souza and P.V. Devarajan, 2013. Inorganic Nanovectors for Nucleic Acid Delivery. Drug Delivery Trans. Res., 3: 446-470.
    CrossRef  |  Direct Link  |  
  15. Patel, M.D., V.C. Malshe and P.V. Devarajan, 2013. Bioenhanced Polymeric Nanoparticulate Compositions of an Anti-Tubercular-Anti-HIV Drug Combination. Am. J. Pharmtech. res., 3: 269-282.
  16. More, A.B., M.D. Patel, V.C. Malshe, P.V. Devarajan and G.R. Vanage, 2013. Genotoxicity And Mutagenicity Evaluation Of Polyethylene Sebacate Nanoparticles. J. Nanopharmaceutics Drug Delivery, 1: 301-310.
    CrossRef  |  Direct Link  |  
  17. Jansch, M., A.B. Jindal, S.B. Majee, A. Samad, P.V. Devarajan and R.H. Muller, 2013. Influence of particle shape on plasma protein adsorption and macrophage uptake. Die Pharmazie Int. J. Pharma. Sci., 68: 27-33.
    CrossRef  |  Direct Link  |  
  18. D`Souza, A.A., P. Jain, C.N. Galdhar, A. Samad, M.S. Degani and P.V. Devarajan, 2013. Comparative in silico-in vivo evaluation of ASGP-R Ligands for hepatic targeting of Curcumin Gantrez nanoparticles. AAPS J., 15: 696-706.
    CrossRef  |  Direct Link  |  
  19. D`Souza, A. and P.V. Devarajan, 2013. Rapid and simultaneous HPLC analysis of curcumin and its metabolite, tetrahydrocurcumin from plasma and liver homogenates. J. Liq. Chromatogr. Relat Technol., 36: 1788-1801.
    CrossRef  |  Direct Link  |  
  20. Patel, M.D., P.V. Date, S.B. Majee, A. Samad and P.V. Devarajan, 2012. Ionic complexation as a non-covalent approach for the design of folate anchored rifampicin gantrez nanoparticles. J. Biomed. Nanotechnol., 9: 765-775.
    CrossRef  |  Direct Link  |  
  21. Kapse, S.V., R.V. Gaikwad, A. Samad and P.V. Devarajan, 2012. Self Nanoprecipitating preconcentrate of tamoxifen citrate for enhanced bioavailability. Int. J. Pharma., 429: 104-112.
    CrossRef  |  Direct Link  |  
  22. D`Souza, A., S. Pranatharthiharan and P.V. Devarajan, 2012. Nanomedicine in Nucleic Acid Therapy. In: Patenting Nanomedicines Souto, E.B. (Ed.). Springer, India, pp 205-249.
    CrossRef  |  Direct Link  |  
  23. Alany, R.G., S. Bhattarai, S. Pranatharthiharan and P.V. Devarajan, 2012. Intramammary Delivery Technologies for Cattle Mastitis Treatment. In: Long Acting Animal Health Drug Products Rathbone, M.J. and A. McDowell, Springer, India, pp 295-327.
    CrossRef  |  Direct Link  |  
  24. Subashini, M., P.V. Devarajan, G.S. Sonavane and M. Doble, 2011. Molecular dynamics simulation of drug uptake by polymer. J. Mol. Model., 17: 1141-1147.
    CrossRef  |  Direct Link  |  
  25. Shinde, R.L., A.B. Jindal and P.V. Devarajan, 2011. Microemulsions and Nanoemulsions for Targeted Drug Delivery to the Brain. Curr. Nanosci., 7: 119-133.
    CrossRef  |  Direct Link  |  
  26. Benival, D.M. and P.V. Devarajan, 2011. Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability. Int. J. Pharma., 423: 554-561.
    CrossRef  |  Direct Link  |  
  27. Guhagarkar, S.A., S.B. Majee, A. Samad and P.V. Devarajan, 2010. Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in Hep G2 cell line. Cancer Nanotechnol., 2: 49-55.
    CrossRef  |  Direct Link  |  
  28. Guhagarkar, S.A., R.V. Gaikwad, A. Samad, V.C. Malshe and P.V. Devarajan, 2010. Polyethylene sebacate-doxorubicin nanoparticles for hepatic targeting. Int. J. Pharma., 401: 113-122.
    CrossRef  |  Direct Link  |  
  29. Devarajan, P.V., A.B. Jindal, R.R. Patil, F. Mulla, R.V. Gaikwad and A. Samad, 2010. Particle shape: A new design parameter for passive targeting in splenotropic drug delivery. J. Pharm. Sci., 99: 2576-2581.
    CrossRef  |  Direct Link  |  
  30. Date, P.V., A. Samad and P.V. Devarajan, 2010. Freeze Thaw: A Simple Approach for Prediction of Optimal Cryoprotectant for Freeze Drying. AAPS Pharm. Sci. Tech., 11: 304-313.
    CrossRef  |  Direct Link  |  
  31. More, A.B., S.N. Chilgunde, J.C. Kamble, P.S. Patil, V.C. Malshe, G.R. Vanage and P.V. Devarajan, 2009. Polyethylene sebacate: Genotoxicity, mutagenicity evaluation and application in periodontal drug delivery system. J. Pharm. Sci., 98: 4781-4795.
    CrossRef  |  Direct Link  |  
  32. Guhagarkar, S. and P.V. Devarajan, 2009. Nanoparticles of Polyethylene sebacate: a new biodegradable polymer. AAPS Pharmscitech, 10: 935-942.
    CrossRef  |  Direct Link  |  
  33. Patil, R.R., S.A. Guhagarkar and P.V. Devarajan, 2008. Engineered nanocarriers of doxorubicin: a current update. Crit. Rev. ther. drug carrier syst., 25: 1-61.
    CrossRef  |  Direct Link  |  
  34. Patil, R.R., R.V. Gaikwad, A. Samad and P.V. Devarajan, 2008. Role of lipids in enhancing splenic uptake of polymer-lipid nanoparticles. J. Biomed. Nanotechnol., 4: 359-366.
    CrossRef  |  Direct Link  |  
  35. Ganeshchandra, S.S. and P.V. Devarajan, 2007. Preparation of Alginate Nanoparticles Using Eudragit E100 as a New Complexing Agent: Development, In-Vitro and In-Vivo Evaluation. J. Biomed. Nanotechnol., 3: 160-169.
    CrossRef  |  Direct Link  |  
  36. Dabholkar, R.D., R.M. Sawant, D.A. Mongayt, P.V. Devarajan and V.P. Torchilin, 2006. Polyethylene glycol�phosphatidylethanolamine conjugate (PEG�PE)-based mixed micelles: Some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Int. J. Pharma. 315: 148-157.
    CrossRef  |  Direct Link  |  
  37. Devarajan, P.V., G.S. Sonavane and M. Doble, 2005. Computer aided molecular modeling: A predictive approach in design of nanoparticulate drug delivery systems. J. Biomed. Nanotechnol., 1: 375-383.
    CrossRef  |  Direct Link  |  
  38. Devarajan, P.V., M.H. Adani and A.S. Gandhi, 2000. Simultaneous Determination Of Lignocaine hydrochloride And Phenylephrine Hydrochloride By High Performance Thin Layer Chromatography. J. Pharma. Biomed. Anal., 22: 685-690.
    CrossRef  |  Direct Link  |